Monopar Therapeutics Inc. (MNPR)
NASDAQ·Healthcare·Biotechnology
$106.51
-2.37%
Mkt Cap $736.03M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (14 analysts)
$115.00
Range $115.00 – $115.00
Implied Upside
+8.0%
Consensus $115.00 vs current $106.51
NASDAQ·Healthcare·Biotechnology
$106.51
-2.37%
Mkt Cap $736.03M
Buy
6
Hold
0
Sell
0
Price Target (14 analysts)
$115.00
Range $115.00 – $115.00
+8.0%
Consensus $115.00 vs current $106.51